MMP9 and myocardial infarction: In summary, the results of the study reported here suggest that donepezil inhibits MMP-9 in macrophages which infiltrate into the infarcted myocardium, thereby contributes at least in part to the reduction of the risk in left ventricular free wall rupture during the acute phase of MI.